XTANT MEDICAL (Germany) Today
| XMS Stock | EUR 0.34 0.01 3.03% |
Performance0 of 100
| Odds Of DistressOver 52
|
XTANT MEDICAL is trading at 0.34 as of the 23rd of December 2024. This is a 3.03 percent up since the beginning of the trading day. The stock's lowest day price was 0.34. XTANT MEDICAL has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 23rd of November 2024 and ending today, the 23rd of December 2024. Click here to learn more.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. The company has 108.66 M outstanding shares. More on XTANT MEDICAL HLDGS
Moving against XTANT Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
XTANT Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. XTANT MEDICAL's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding XTANT MEDICAL or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Medical Devices, Healthcare (View all Sectors) |
XTANT MEDICAL HLDGS (XMS) is traded on Frankfurt Exchange in Germany and employs 116 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate XTANT MEDICAL's market, we take the total number of its shares issued and multiply it by XTANT MEDICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. XTANT MEDICAL HLDGS classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 108.66 M outstanding shares.
XTANT MEDICAL HLDGS has accumulated about 20.31 M in cash with 1.79 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check XTANT MEDICAL Probability Of Bankruptcy
Ownership AllocationXTANT MEDICAL HLDGS secures a total of 108.66 Million outstanding shares. The majority of XTANT MEDICAL HLDGS outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to purchase positions in XTANT MEDICAL HLDGS to benefit from reduced commissions. Therefore, outside corporations are subject to a different set of regulations than regular investors in XTANT MEDICAL HLDGS. Please pay attention to any change in the institutional holdings of XTANT MEDICAL as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check XTANT Ownership Details
XTANT MEDICAL HLDGS Risk Profiles
Although XTANT MEDICAL's alpha and beta are two of the key measurements used to evaluate XTANT MEDICAL's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.23 | |||
| Standard Deviation | 5.2 | |||
| Variance | 27.08 | |||
| Risk Adjusted Performance | (0.05) |
XTANT Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in XTANT MEDICAL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Other Information on Investing in XTANT Stock
XTANT MEDICAL financial ratios help investors to determine whether XTANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTANT with respect to the benefits of owning XTANT MEDICAL security.